Copyright
©The Author(s) 2023.
World J Immunol. May 31, 2023; 13(1): 1-10
Published online May 31, 2023. doi: 10.5411/wji.v13.i1.1
Published online May 31, 2023. doi: 10.5411/wji.v13.i1.1
Patient number | ||
Clinical features | Epileptic seizures | 7/14 |
Cognitive impairment | 6/14 | |
Motor deficit | 4/14 | |
Movement disorders | 5/14 | |
Ataxia | 3/14 | |
Pain/Headache | 4/14 | |
Behavioral changes | 4/14 | |
Psychiatric features | 2/14 | |
Laboratory analysis | Cell blood count changes | 6/14 |
High C-reactive protein level | 5/14 | |
High sedimentation velocity rate | 3/14 | |
CSF analysis: Pleiocytosis | 6/14 | |
High protein level | 5/14 | |
High IgG index | 1/14 | |
Auto-antibodies | 8/14 | |
Neuroimaging | Cortex involvement | 4/14 |
Basal ganglia involvement | 2/14 | |
White matter involvement | 6/14 |
- Citation: Zouari Mallouli S, Jallouli O, Bouchaala W, Ben Nsir S, Kamoun Feki F, Charfi Triki C. Challenges to associate early onset epilepsy with COVID-19 autoimmune encephalitis: A case report. World J Immunol 2023; 13(1): 1-10
- URL: https://www.wjgnet.com/2219-2824/full/v13/i1/1.htm
- DOI: https://dx.doi.org/10.5411/wji.v13.i1.1